Rapid ASPECTS vs Viz ANEURYSM
AI Verdict
Choose Rapid ASPECTS if…
Choose Rapid ASPECTS if your primary need is rapid, automated assessment of early ischemic changes in acute stroke patients using non-contrast CT scans. This tool is ideal for improving diagnostic accuracy and standardizing ASPECTS scoring to quickly determine thrombectomy eligibility, enhancing workflow efficiency in time-sensitive stroke care.
View Rapid ASPECTS →Choose Viz ANEURYSM if…
Choose Viz ANEURYSM if your focus is on the automated detection and coordinated management of suspected cerebral aneurysms from CT angiograms. This solution is best suited for streamlining neurovascular care pathways, enabling real-time communication among care teams, and facilitating timely referrals and follow-up for patients with potential aneurysms.
View Viz ANEURYSM →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Rapid ASPECTS | Viz ANEURYSM |
|---|---|---|
| Pricing | Annual subscription model; pricing varies by region, hospital type, modules, and imaging modalities. starts at approximately $12,000 for a single module in the united states. | Contact for pricing |
| Deployment | Software as a Medical Device (SaMD), delivered via PACS, email, and mobile/web applications (cloud-based). | Cloud-based; Standalone application; Mobile software module |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | 1 AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz ANEURYSMViz ANEURYSM offers a more comprehensive and integrated user experience by focusing on AI-enhanced 3D imaging, interactive tools, real-time notifications, secure messaging for care team coordination, and one-click referral activation. Its seamless integration with EHR and PACS solutions further streamlines workflows and provides contextual patient information at the point of care.
Clinical Value
Rapid ASPECTSRapid ASPECTS provides clear, quantifiable clinical benefits, including improved clinician diagnostic accuracy (shown to improve by 10%) and increased reader reliability and reduced intra-reader variability for ASPECTS scoring. It is also noted as the only clinically validated software with an FDA indication to aid in the selection of acute stroke therapy patients, providing detailed CTP maps for critical decision-making.
Pricing & Value
Rapid ASPECTSRapid ASPECTS offers greater pricing transparency by providing a starting price of approximately $12,000 for a single module in the United States. In contrast, Viz ANEURYSM requires potential customers to contact them for pricing details, making initial budgeting and comparison more challenging.
Enterprise Readiness
Viz ANEURYSMBoth tools are FDA-cleared, HIPAA compliant, and offer BAAs, demonstrating strong foundational readiness. However, Viz ANEURYSM explicitly targets 'Enterprise (Hospital/Health System)' and emphasizes its 'AI-powered care coordination solution' with seamless integration across EHR, PACS, and cloud environments, supported by partnerships like Microsoft, indicating a broader and more deeply integrated enterprise vision for system-wide intelligence and care pathways.
Innovation
Viz ANEURYSMWhile Rapid ASPECTS offers deep clinical AI for stroke analysis, Viz ANEURYSM demonstrates broader innovation by extending beyond detection to a comprehensive AI-powered care coordination platform. This includes real-time notifications, secure messaging, and one-click referral activation across multiple disease areas with over 50 FDA-cleared algorithms, and the capability to build and scale custom care pathways through Viz Agent Studio.
Support & Docs
Rapid ASPECTSRapidAI offers 24/7/365 customer support worldwide via both phone and email, ensuring consistent and comprehensive assistance. While Viz.ai provides 24/7 urgent phone support with a 15-minute callback guarantee, its email support operates on a 'next business day' response, which is less immediate than RapidAI's stated full-time coverage for both channels.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Rapid ASPECTS | Viz ANEURYSM |
|---|---|---|
| Tool Name | Rapid ASPECTS | Viz ANEURYSM |
| Company | RapidAI | Viz.ai |
| Primary Clinical Focus | Quantify early ischemic changes and aid in determining thrombectomy eligibility for stroke patients. | Auto-detects suspected cerebral aneurysms in CT angiograms (CTAs), streamlining neurovascular care coordination and facilitating timely patient management. |
| Input Imaging Modality | Non-contrast CT scans | CT angiograms (CTAs) |
| Core Functionality | Automated ASPECTS score generation; Visualization of regions of asymmetry and ischemic change; Fast results delivery (under 2 minutes). | Auto-detection of suspected cerebral aneurysms; AI-enhanced 3D imaging (Viz 3D CTA); Real-time notification to appropriate care providers. |
Videos
Demos, reviews, and walkthroughs featuring Rapid ASPECTS and Viz ANEURYSM.